Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient

American Journal of Medical Genetics, Part A - Tập 137A Số 1 - Trang 22-26 - 2005
Liangwu Sun1, Erik A. Eklund1, Johan L.K. Van Hove2, Hudson H. Freeze1, Janet A. Thomas2
1The Burnham Institute, La Jolla, California
2Department of Pediatrics, University of Colorado Health Sciences Center, The Children's Hospital, Denver, Colorado

Tóm tắt

AbstractCongenital disorder of glycosylation (CDG) type Ic, the second largest subtype of CDG, is caused by mutations in human ALG6 (hALG6). This gene encodes the α1,3‐glucosyltransferase that catalyzes transfer of the first glucose residue to the lipid‐linked oligosaccharide precursor for N‐linked glycosylation. In this report, we describe the first adult patient diagnosed with CDG‐Ic, carrying two previously unknown mutations. The first is a three base deletion (897‐899delAAT) leading to the loss of I299, the second is an intronic mutation (IVS7 + 2T > G) that causes aberrant splicing. Wildtype hALG6, delivered by a lentiviral vector into patient's fibroblasts, clearly improves the biochemical phenotype, which confirms that the mutations are disease‐causing. Striking clinical findings include limb deficiencies in the fingers, resembling brachydactyly type B, a deep vein thrombosis, pseudotumor cerebri, and endocrine disturbances with pronounced hyperandrogenism and virilization. However, even in adulthood, this patient shows normal magnetic resonance imaging of the brain. © 2005 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1023/A:1005323700680

10.1172/JCI2266

10.1203/00006450-199504000-00003

10.1016/j.ymgme.2004.09.014

10.1016/S0304-4165(02)00408-7

10.1002/1531-8249(200006)47:6<776::AID-ANA10>3.0.CO;2-5

10.1073/pnas.96.12.6982

10.1023/A:1024431131208

10.1097/00019052-200112000-00021

Jaeken J, 2001, The metabolic and molecular bases of inherited disease, 1601

Krakow D, 2002, Emery and Rimoin's principles and practice of medical genetics, 4160

10.1111/j.1651-2227.1995.tb13720.x

10.1007/s00431-002-1136-0

Masiakowski P, 1992, A novel family of cell surface receptors with tyrosine kinase‐like domain, J Biol Chem, 267, 26181, 10.1016/S0021-9258(18)35733-8

10.1023/A:1021883605280

10.1016/S1096-7192(03)00089-1

Oldridge M, 2004, Inborn errors of development the molecular basis of clinical disorders of morphogenesis, 886

10.1002/glia.20023

10.1136/adc.74.3.242

10.1006/mgme.2000.3017

10.1006/mgme.2001.3161